CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Contineum Therapeutics Publishes Discovery of Potential Best-in-Class LPAR1 Antagonist PIPE-791 in Journal of Medicinal Chemistry

PIPE-791Positive
AI Analysis

Summary

Contineum Therapeutics published research on PIPE-791, a potential best-in-class LPAR1 antagonist, in the Journal of Medicinal Chemistry.

Importance:2/10
Sentiment:
0.30
drug discoveryLPAR1 antagonistpublicationpreclinical
Related Companies

Read the original article

Published by yahoo_finance on June 30, 2026 8:05 PM

Read Original